Pulczynski EJ, Simonsen MR, Kuittinen O, Fagerli U-M, Erlanson M, Fluge Øystein, Leppä S, Østenstad B, Fosså A, Eriksson M, El-Galaly T, Kuitunen H, Papworth K, Ljungqvist M, Pedersen MB, Pollari M. Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up. Haematologica 2024;109(7):2359-2363; https://doi.org/10.3324/haematol.2024.285207.